Thomas Metz

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Systemic Lupus Erythematosus

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Vuaroqueaux, Alexandra Musch, Anne-Lise Peille, Gerhard Kelter, Loreen Weichert, Thomas Metz, Hans R Hendriks, Heinz-Herbert Fiebig
High in vitro and in vivo activity of BI-847325, a dual MEK/Aurora kinase inhibitor, in human solid and hematologic cancer models. Cancer research communications (2023)